Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
72
DOX Quote, Financials, Valuation and Earnings
Last price:
$81.75
Seasonality move
:
10.35%
Day range:
$80.74 - $81.77
52-week range:
$74.32 - $95.41
Dividend yield:
2.52%
P/E ratio:
16.17x
P/S ratio:
2.00x
P/B ratio:
2.57x
Volume:
530K
Avg. volume:
1.2M
1-year change:
-5.73%
Market cap:
$8.8B
Revenue:
$4.5B
EPS (TTM):
$5.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DOX
Amdocs Ltd.
|
$1.2B | $1.81 | 3.91% | 29.5% | $102.50 |
|
ASGN
ASGN Incorporated
|
$967.5M | $0.98 | -1.4% | 22.08% | $49.67 |
|
CDW
CDW Corp.
|
$5.3B | $2.20 | 2.84% | 24.13% | $180.60 |
|
CNXC
Concentrix Corp.
|
$2.5B | $2.90 | 3.72% | 69.29% | $63.60 |
|
INLX
Intellinetics, Inc.
|
$4.6M | -- | -3.16% | -- | $14.50 |
|
WYY
WidePoint Corp.
|
$39.8M | -- | 6.83% | -- | $9.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DOX
Amdocs Ltd.
|
$81.73 | $102.50 | $8.8B | 16.17x | $0.53 | 2.52% | 2.00x |
|
ASGN
ASGN Incorporated
|
$50.02 | $49.67 | $2.1B | 16.87x | $0.00 | 0% | 0.55x |
|
CDW
CDW Corp.
|
$139.71 | $180.60 | $18.2B | 17.67x | $0.63 | 1.79% | 0.84x |
|
CNXC
Concentrix Corp.
|
$41.96 | $63.60 | $2.6B | 8.87x | $0.36 | 3.24% | 0.27x |
|
INLX
Intellinetics, Inc.
|
$8.14 | $14.50 | $36.5M | 248.75x | $0.00 | 0% | 2.11x |
|
WYY
WidePoint Corp.
|
$5.31 | $9.33 | $52.5M | -- | $0.00 | 0% | 0.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DOX
Amdocs Ltd.
|
19.42% | -0.026 | 9.88% | 0.95x |
|
ASGN
ASGN Incorporated
|
40.34% | 1.274 | 60.74% | 1.81x |
|
CDW
CDW Corp.
|
70.57% | 1.431 | 29.34% | 1.14x |
|
CNXC
Concentrix Corp.
|
56.83% | -0.566 | 174.23% | 1.30x |
|
INLX
Intellinetics, Inc.
|
14.18% | -0.662 | 3.65% | 0.89x |
|
WYY
WidePoint Corp.
|
28.75% | -0.059 | 10.28% | 0.93x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DOX
Amdocs Ltd.
|
$413.5M | $202M | 13.06% | 16.07% | 17.56% | $198.6M |
|
ASGN
ASGN Incorporated
|
$280.1M | $67.9M | 4.33% | 7.26% | 6.71% | $72M |
|
CDW
CDW Corp.
|
$1.3B | $444.4M | 12.06% | 43.69% | 7.75% | $298.5M |
|
CNXC
Concentrix Corp.
|
$685.9M | $164.9M | 3.05% | 7.22% | 6.64% | $159.7M |
|
INLX
Intellinetics, Inc.
|
$2.3M | -$379.2K | -12.47% | -15.79% | -9.48% | $1.1M |
|
WYY
WidePoint Corp.
|
$5M | -$460.6K | -12.59% | -17.34% | -1.28% | $5.9M |
Amdocs Ltd. vs. Competitors
-
Which has Higher Returns DOX or ASGN?
ASGN Incorporated has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of 3.77%. Amdocs Ltd.'s return on equity of 16.07% beat ASGN Incorporated's return on equity of 7.26%.
Company Gross Margin Earnings Per Share Invested Capital DOXAmdocs Ltd.35.95% $0.86 $4.3B ASGNASGN Incorporated27.69% $0.87 $3.1B -
What do Analysts Say About DOX or ASGN?
Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 25.41%. On the other hand ASGN Incorporated has an analysts' consensus of $49.67 which suggests that it could fall by -0.71%. Given that Amdocs Ltd. has higher upside potential than ASGN Incorporated, analysts believe Amdocs Ltd. is more attractive than ASGN Incorporated.
Company Buy Ratings Hold Ratings Sell Ratings DOXAmdocs Ltd.3 1 0 ASGNASGN Incorporated3 2 2 -
Is DOX or ASGN More Risky?
Amdocs Ltd. has a beta of 0.426, which suggesting that the stock is 57.443% less volatile than S&P 500. In comparison ASGN Incorporated has a beta of 0.881, suggesting its less volatile than the S&P 500 by 11.874%.
-
Which is a Better Dividend Stock DOX or ASGN?
Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.52%. ASGN Incorporated offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. ASGN Incorporated pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DOX or ASGN?
Amdocs Ltd. quarterly revenues are $1.2B, which are larger than ASGN Incorporated quarterly revenues of $1B. Amdocs Ltd.'s net income of $95.3M is higher than ASGN Incorporated's net income of $38.1M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.17x while ASGN Incorporated's PE ratio is 16.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.00x versus 0.55x for ASGN Incorporated. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DOXAmdocs Ltd.2.00x 16.17x $1.2B $95.3M ASGNASGN Incorporated0.55x 16.87x $1B $38.1M
-
Which has Higher Returns DOX or CDW?
CDW Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of 5.07%. Amdocs Ltd.'s return on equity of 16.07% beat CDW Corp.'s return on equity of 43.69%.
Company Gross Margin Earnings Per Share Invested Capital DOXAmdocs Ltd.35.95% $0.86 $4.3B CDWCDW Corp.21.88% $2.21 $8.6B -
What do Analysts Say About DOX or CDW?
Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 25.41%. On the other hand CDW Corp. has an analysts' consensus of $180.60 which suggests that it could grow by 29.27%. Given that CDW Corp. has higher upside potential than Amdocs Ltd., analysts believe CDW Corp. is more attractive than Amdocs Ltd..
Company Buy Ratings Hold Ratings Sell Ratings DOXAmdocs Ltd.3 1 0 CDWCDW Corp.6 4 0 -
Is DOX or CDW More Risky?
Amdocs Ltd. has a beta of 0.426, which suggesting that the stock is 57.443% less volatile than S&P 500. In comparison CDW Corp. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.642%.
-
Which is a Better Dividend Stock DOX or CDW?
Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.52%. CDW Corp. offers a yield of 1.79% to investors and pays a quarterly dividend of $0.63 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. CDW Corp. pays out 31.17% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DOX or CDW?
Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than CDW Corp. quarterly revenues of $5.7B. Amdocs Ltd.'s net income of $95.3M is lower than CDW Corp.'s net income of $291M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.17x while CDW Corp.'s PE ratio is 17.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.00x versus 0.84x for CDW Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DOXAmdocs Ltd.2.00x 16.17x $1.2B $95.3M CDWCDW Corp.0.84x 17.67x $5.7B $291M
-
Which has Higher Returns DOX or CNXC?
Concentrix Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of 3.38%. Amdocs Ltd.'s return on equity of 16.07% beat Concentrix Corp.'s return on equity of 7.22%.
Company Gross Margin Earnings Per Share Invested Capital DOXAmdocs Ltd.35.95% $0.86 $4.3B CNXCConcentrix Corp.27.62% $1.34 $10.1B -
What do Analysts Say About DOX or CNXC?
Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 25.41%. On the other hand Concentrix Corp. has an analysts' consensus of $63.60 which suggests that it could grow by 51.57%. Given that Concentrix Corp. has higher upside potential than Amdocs Ltd., analysts believe Concentrix Corp. is more attractive than Amdocs Ltd..
Company Buy Ratings Hold Ratings Sell Ratings DOXAmdocs Ltd.3 1 0 CNXCConcentrix Corp.2 2 0 -
Is DOX or CNXC More Risky?
Amdocs Ltd. has a beta of 0.426, which suggesting that the stock is 57.443% less volatile than S&P 500. In comparison Concentrix Corp. has a beta of 0.551, suggesting its less volatile than the S&P 500 by 44.858%.
-
Which is a Better Dividend Stock DOX or CNXC?
Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.52%. Concentrix Corp. offers a yield of 3.24% to investors and pays a quarterly dividend of $0.36 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. Concentrix Corp. pays out 33.39% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DOX or CNXC?
Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than Concentrix Corp. quarterly revenues of $2.5B. Amdocs Ltd.'s net income of $95.3M is higher than Concentrix Corp.'s net income of $83.9M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.17x while Concentrix Corp.'s PE ratio is 8.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.00x versus 0.27x for Concentrix Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DOXAmdocs Ltd.2.00x 16.17x $1.2B $95.3M CNXCConcentrix Corp.0.27x 8.87x $2.5B $83.9M
-
Which has Higher Returns DOX or INLX?
Intellinetics, Inc. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of -9.24%. Amdocs Ltd.'s return on equity of 16.07% beat Intellinetics, Inc.'s return on equity of -15.79%.
Company Gross Margin Earnings Per Share Invested Capital DOXAmdocs Ltd.35.95% $0.86 $4.3B INLXIntellinetics, Inc.56.29% -$0.08 $13.3M -
What do Analysts Say About DOX or INLX?
Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 25.41%. On the other hand Intellinetics, Inc. has an analysts' consensus of $14.50 which suggests that it could grow by 78.13%. Given that Intellinetics, Inc. has higher upside potential than Amdocs Ltd., analysts believe Intellinetics, Inc. is more attractive than Amdocs Ltd..
Company Buy Ratings Hold Ratings Sell Ratings DOXAmdocs Ltd.3 1 0 INLXIntellinetics, Inc.0 0 0 -
Is DOX or INLX More Risky?
Amdocs Ltd. has a beta of 0.426, which suggesting that the stock is 57.443% less volatile than S&P 500. In comparison Intellinetics, Inc. has a beta of 0.272, suggesting its less volatile than the S&P 500 by 72.768%.
-
Which is a Better Dividend Stock DOX or INLX?
Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.52%. Intellinetics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. Intellinetics, Inc. pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DOX or INLX?
Amdocs Ltd. quarterly revenues are $1.2B, which are larger than Intellinetics, Inc. quarterly revenues of $4M. Amdocs Ltd.'s net income of $95.3M is higher than Intellinetics, Inc.'s net income of -$369.8K. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.17x while Intellinetics, Inc.'s PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.00x versus 2.11x for Intellinetics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DOXAmdocs Ltd.2.00x 16.17x $1.2B $95.3M INLXIntellinetics, Inc.2.11x 248.75x $4M -$369.8K
-
Which has Higher Returns DOX or WYY?
WidePoint Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of -1.55%. Amdocs Ltd.'s return on equity of 16.07% beat WidePoint Corp.'s return on equity of -17.34%.
Company Gross Margin Earnings Per Share Invested Capital DOXAmdocs Ltd.35.95% $0.86 $4.3B WYYWidePoint Corp.13.98% -$0.06 $17.1M -
What do Analysts Say About DOX or WYY?
Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 25.41%. On the other hand WidePoint Corp. has an analysts' consensus of $9.33 which suggests that it could grow by 75.77%. Given that WidePoint Corp. has higher upside potential than Amdocs Ltd., analysts believe WidePoint Corp. is more attractive than Amdocs Ltd..
Company Buy Ratings Hold Ratings Sell Ratings DOXAmdocs Ltd.3 1 0 WYYWidePoint Corp.3 0 0 -
Is DOX or WYY More Risky?
Amdocs Ltd. has a beta of 0.426, which suggesting that the stock is 57.443% less volatile than S&P 500. In comparison WidePoint Corp. has a beta of 1.284, suggesting its more volatile than the S&P 500 by 28.408%.
-
Which is a Better Dividend Stock DOX or WYY?
Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.52%. WidePoint Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. WidePoint Corp. pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DOX or WYY?
Amdocs Ltd. quarterly revenues are $1.2B, which are larger than WidePoint Corp. quarterly revenues of $36.1M. Amdocs Ltd.'s net income of $95.3M is higher than WidePoint Corp.'s net income of -$559.2K. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.17x while WidePoint Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.00x versus 0.35x for WidePoint Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DOXAmdocs Ltd.2.00x 16.17x $1.2B $95.3M WYYWidePoint Corp.0.35x -- $36.1M -$559.2K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
